Evidence map›Paper›PMID 38162725›Full record

ArticleACS omega2023

Multiwavelength SERS of Magneto-Plasmonic Nanoparticles Obtained by Combined Laser Ablation and Solvothermal Methods.

Martynas Talaikis, Lina Mikoliunaite, Aikaterini-Maria Gkouzi, Vita Petrikaitė, Evaldas Stankevičius, Audrius Drabavičius, Algirdas Selskis, Remigijus Juškėnas, Gediminas Niaura

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Martynas TalaikisDepartment of Organic Chemistry, Center for Physical Sciences and Technology (FTMC), Saulėtekio Av. 3, LT-10257 Vilnius, Lithuania.ORCID https://orcid.org/0000-0003-3516-6425
Lina MikoliunaiteDepartment of Organic Chemistry, Center for Physical Sciences and Technology (FTMC), Saulėtekio Av. 3, LT-10257 Vilnius, Lithuania.
Aikaterini-Maria GkouziDepartment of Organic Chemistry, Center for Physical Sciences and Technology (FTMC), Saulėtekio Av. 3, LT-10257 Vilnius, Lithuania.
Vita PetrikaitėDepartment of Laser Technologies, Center for Physical Sciences and Technology (FTMC), Savanorių Av. 231, LT-02300 Vilnius, Lithuania.
Evaldas StankevičiusDepartment of Laser Technologies, Center for Physical Sciences and Technology (FTMC), Savanorių Av. 231, LT-02300 Vilnius, Lithuania.ORCID https://orcid.org/0000-0003-3783-5506
Audrius DrabavičiusDepartment of Characterization of Materials Structure, Center for Physical Sciences and Technology (FTMC), Saulėtekio Av. 3, LT-10257 Vilnius, Lithuania.
Algirdas SelskisDepartment of Characterization of Materials Structure, Center for Physical Sciences and Technology (FTMC), Saulėtekio Av. 3, LT-10257 Vilnius, Lithuania.
Remigijus JuškėnasDepartment of Characterization of Materials Structure, Center for Physical Sciences and Technology (FTMC), Saulėtekio Av. 3, LT-10257 Vilnius, Lithuania.
Gediminas NiauraDepartment of Organic Chemistry, Center for Physical Sciences and Technology (FTMC), Saulėtekio Av. 3, LT-10257 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-2136-479X
Center for Physical Sciences and Technology · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study introduces a novel method for the synthesis of magneto-plasmonic nanoparticles (MPNPs) with enhanced functionality for surface-enhanced Raman scattering (SERS) applications. By employing pulsed laser ablation in liquid (PLAL) to synthesize plasmonic nanoparticles and wet chemistry to synthesize magnetic nanoparticles, we successfully fabricated chemically pure hybrid Fe

Identifiers

PMID38162725
PMCPMC10753541
OpenAlexW4389733242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.